ERYTECH’s IPO a remarkable success, raising €17.7 million

Post author:admERY
Post published:April 30, 2013
Post category:Newsroom

ERYTECH today announced the success of its IPO in compartment C of the NYSE Euronext regulated market in Paris, raising more than the target amount of €15 million.

You Might Also Like

ERYTECH Selects Triple Negative Breast Cancer as Next Indication for Eryaspase

ERYTECH Strengthens Executive Leadership Team with Appointments of Chief Scientific Officer and Chief Business Officer

ERYTECH Appoints Allene M. Diaz to its Board of Directors